期刊文献+

临床药师参与的血药浓度危急值管理实践 被引量:4

A Novel Management Practice for Urgent Value of Plasma Drug Concentration with the Participation of Clinical Pharmacists
下载PDF
导出
摘要 血药浓度危急值管理具有其特殊性,既是医院危急值管理的一部分,也是规范临床用药、保障患者用药安全的重要手段。因此,医院应重视血药浓度危急值的管理,针对临床检测发现的血药浓度危急值,应及时反馈、沟通处理。在医疗改革日益深化的今天,专科临床药师是医院药学技术服务转型的主力军。本院从2013年起,临床药师、检测药师和医护人员共同参与、逐步探索,建立了患者的血药浓度危急值管理和临床干预体系,对临床检测的血药浓度危急值进行预警、跟踪和临床干预。所建立的血药浓度危急值管理模式,显著提高了我院血药浓度危急值的上报率,同时也降低了危急值患者药品不良反应的发生率。 The management of urgent value for therapeutic drug monitoring is not only part of urgent value management in hospitals,but also an important tool for ensuring reasonable drug usage and patient's safety.Therefore,it is necessary for hospitals to pay attention to urgent value in therapeutic drug monitoring,and further clinical intervention and response is needed.With the new medical reform,clinical pharmacists are playing more and more important roles in providing pharmaceutical services.A novel urgent value management and clinical intervention system for therapeutic drug monitoring which includes the participation of clinical pharmacists,technicians and medical staffs has been established in our hospital since 2013.It has improved the reporting rate of urgent values,and cut down the incidence rate of adverse drug reactions significantly.
作者 刘晓媛 周少丹 徐佳 韩懿丹 袁文博 LIU Xiaoyuan;ZHOU Shaodan;XU Jia;HAN Yidan;YUAN Wenbo(Department of Pharmaceutical,Affiliated Hospital of Jiangnan University,Wuxi,Jiangsu,214062,China)
出处 《药学与临床研究》 2019年第2期152-154,共3页 Pharmaceutical and Clinical Research
基金 无锡市卫生计生委青年基金项目(Q201632 Q201647) 无锡市科技发展医疗卫生指导性项目
关键词 血药浓度危急值 临床干预 个体化用药 Urgent value of plasma concentration Clinical intervention Individualized medication
  • 相关文献

参考文献7

二级参考文献43

  • 1张真路,刘泽金,赵耿生,杨军,王文武,崔敏.临床实验室危急值的建立与应用[J].中华检验医学杂志,2005,28(4):452-453. 被引量:149
  • 2Bond C,Raehl C,Franke T.Clinical pharmacy services,hospital pharmacy staffing,and medication errors in the United States hospitals[J].Pharmacotherapy,2002,22 (2):134-147.
  • 3吴永佩 吕红梅 颜青.加速临床药师制建设促进医疗团队建立.中国医院,2009,13(11):2-5.
  • 4Kost G J, Hale K N. Global trends in critical values practices and their harmonization[J]. Clin Chem Lab Med, 2011, 49(2): 167-176.
  • 5Barenfanger J, Sautter R L, Lang D L, et al. hnproving patient safety by repeating (read-back) telephone reports of critical information[J]. Am J Clin Pathol, 2004, 121(6): 801 803.
  • 6Valenstein P N, Wagar E A, Stankovic A K, et id. Notification of crit- ical results: a College of American Pathologists Q-Probes study of 121 institutions[J]. Arch Pathol Lab Med, 2008, 132(12): 1862-1867.
  • 7Parl F F, O' Leary M F, Kaiser A B, et ol. hnplementation of a closed- loop reporting system for critical values and clinical communication in compliance with goals of the joint commission [J]. Clin Chem, 2010, 56 (3): 417-423.
  • 8Piva E, Sciacovelli L, Zaninotto M, et al. Evaluation of effectiveness of a computerized notification system for reporting critical values[J]. Am J Clin Pathol, 2009, 131(3): 432-441.
  • 9黎永新,雷达,莫建坤,张知洪,黄基伟.在LIS建立危急值、急诊结果报告记录的应用[J].现代医院,2007,7(12):130-131. 被引量:25
  • 10Joint Commission International. Joint Commission Inter- national Accreditation Standards for Hospital EM]. 4th ed. Illinois : Joint Commission Resources, 2011 : 45-48.

共引文献100

同被引文献38

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部